Overview
Oviva has raised €200 million in a Series D funding round to enhance its digital therapy programs for obesity and chronic illnesses, addressing the needs of over 200 million European adults. The funding, sourced from investors including Kinnevik and Planet First Partners, will help expand its offerings into hypertension and type 2 diabetes. The platform integrates a certified medical app with multidisciplinary care teams, providing evidence-based interventions and full reimbursement in Germany, the UK, and Switzerland.
Products
Loading...
Recent Deals
Investors: Kinnevik, Planet First Partners
Oviva has raised €200 million in a Series D funding round to enhance its digital therapy programs for obesity and chronic illnesses, addressing the needs of over 200 million European adults. The funding, sourced from investors including Kinnevik and Planet First Partners, will help expand its offerings into hypertension and type 2 diabetes. The platform integrates a certified medical app with multidisciplinary care teams, providing evidence-based interventions and full reimbursement in Germany, the UK, and Switzerland.